SEI Investments
HTGM

SEI Investments’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

SEI Investments’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-16
Closed -$9K – 3601
2018
Q2 		$9K Hold
16
– – ﹤0.01% 3043
2018
Q1 		$10K Hold
16
– – ﹤0.01% 2888
2017
Q4 		$6K Hold
16
– – ﹤0.01% 2929
2017
Q3 		$5K Buy
16
+6
+60% +$2.28K ﹤0.01% 2851
2017
Q2 		$5K Buy
+10
New +$7.58K ﹤0.01% 2743

Other funds holding HTGM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

SEI Investments's HTGM Position: Q3 2018 in Review

SEI Investments sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2018, closing a stake of 16 shares — an estimated $9K sold.

SEI Investments first reported a position in HTGM in Q2 2017 and held it in 5 quarters. The position peaked at $10K in Q1 2018. 54 funds tracked by Wall St. Rank hold HTGM as of Q3 2018.

  • SEI Investments reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • SEI Investments sold 16 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2018, an estimated $9K.
  • SEI Investments first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2017 and held it in 5 quarters.
  • SEI Investments's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $10K in Q1 2018.
  • 54 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.